Levensohn Venture Partners

Levensohn Venture Partners (LVP) is a venture capital firm based in Los Altos, California, known for its strategic investments in breakthrough technologies across the biotechnology and information technology sectors. Founded by David Levensohn, the firm has a history of identifying and nurturing innovative companies from their early stages. LVP's investment philosophy centers on providing capital and strategic guidance to companies poised for significant market disruption, often focusing on intellectual property-rich companies with strong management teams.

The firm has managed several funds, with notable vehicles including Levensohn Venture Partners III, which closed at approximately $125 million in 2000, and Levensohn Venture Partners IV, which raised around $100 million in 2007. These funds primarily targeted early-stage companies, often participating in Series A rounds. LVP's approach typically involves taking a significant, yet not controlling, stake in its portfolio companies, supporting them through subsequent funding rounds and strategic partnerships, aiming to build long-term value.

LVP has a track record of successful exits, demonstrating its ability to back companies that achieve substantial growth and acquisition. Prominent examples include their investment in NetSuite, a cloud computing company acquired by Oracle for approximately $9.3 billion, and Genomic Health, a precision oncology company acquired by Exact Sciences. Other successful ventures include Xactly, a cloud-based sales performance management software company, and NextBio, a genomics data analysis platform acquired by Illumina. While the firm's most recent fund dates back to 2007, indicating a current focus on managing its existing portfolio, its historical investments highlight a consistent commitment to high-growth, technology-driven enterprises.